Dear Dr [Last name],

Myeloproliferative neoplasms (MPNs), previously known as myeloproliferative disorders (MPDs), are a rare and underserved group of diseases, both in terms of treatment and available educational resources. MPNConnect is a new scientific educational initiative provided to you by Incyte Corporation with the goal of advancing the understanding of MPNs.

MPNConnect focuses on the following 3 Philadelphia chromosome– negative MPNs that are associated with dysregulated Janus kinase (JAK) signaling:

• Myelofibrosis (MF)
• Polycythemia vera (PV)
• Essential thrombocythemia (ET)

MPNConnect aspires to engage healthcare providers and expand the knowledge base of the MPN community. Become a member of MPNConnect today to take advantage of all of the free member resources. As a member, you can

• Download an in-depth brochure about MPNs and the JAK pathway
• Submit disease-related questions to the Scientific Council
• Gain access to relevant MPN publications

Sincerely,
MPNConnect